2109 Anti-EGFR or Bevacizumab in first line treatment of RAS wild type metastatic colorectal neoplasm (RwtMCRC): pooled analysis of randomized clincal trials. (September 2015) - Tamburini, E.; Gianni, L.; Pasini, G.; Papi, M.; Stocchi, L.; Rudnas, B.; Affatato, A.; Drudi, F.; Nicoletti, S.; Santelmo, C.; Ridolfi, C.; Fantini, M.; et al.